CHMP Backs Shingles Vaccine Shingrix for Adults 50 and Older CHMP Backs Shingles Vaccine Shingrix for Adults 50 and Older

The European Medicines Agency ' s CHMP voted to grant marketing authorization for the Shingrix vaccine to prevent herpes zoster and postherpetic neuralgia.International Approvals

Source: Medscape Internal Medicine Headlines - January 26, 2018 Category: Internal Medicine Tags: Infectious Diseases News Alert Source Type: news